Last update: May 17th 2013
April 23th 2013

Choose Transparency: A message to the Members...

The Clinical Trial Regulation is currently being discussed. As patients, researchers, doctors, scientists and civil society representatives we would like to draw your attention not only to the dangers it encompasses but also to the opportunities it brings along.

April 09th 2013

Clinical Trials Regulation Protect public...

The International Society of Drug Bulletins issued a statement today to the members of European Parlament to request:

  • support amendments that require the public disclosure of a complete clinical studyreport (CSR) as outlined by ENVI rapporteur MEP...
February 05th 2013

New Proposal for a Regulation on Clinical Trials

The protection of human subjects must be upheld & citizens’ right to information must be strengthened

September 15th 2012

European Medicines Agency and...

On 18 June 2012, the EU Commission published a draft concept paper for public consultation on the “Introduction of fees to be charged by the European Medicines Agency for pharmacovigilance”.

for members only

Documents of interest

Proposal of the European Commission for a Regulation relating to Medical Devices

November 2012 (305 KB)

Health information

Everyone has their part to playand should keep to it

march 2007 (704 KB)

Cochrane handbook on adverse effects

may 2005 (192 KB)

Helsinki Declaration

Ethical Principles for Medical Research Involving Human Subjects

october 2000 (web access)

Erice Declaration

On Communicating Drug Safety Information

september 1997 (web access)

Uppsala Declaration

Statement of The International Working group on Transparency and Accountability in Drug Regulation

September 1996 (web access)

ISDB - International Society of Drug bullettins

Contact details:
President: president@isdbweb.org
Webmaster: maria.font@ulss20.verona.it

© 2013